| 标题 |
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA |
| 网址 | |
| DOI | |
| 其它 |
期刊:Pharmacoeconomics 作者:Masurkar PP, Damgacioglu H, Deshmukh AA, Trivedi MV 出版日期:2023-03-15 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)